Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share ...

Cantor Fitzgerald has a “Overweight” rating on the stock. The consensus estimate for Tango Therapeutics’ current full-year earnings is ($1.19) per share. Get Tango Therapeutics alerts: ...

Author of 'Swarm Troopers: How small drones will conquer the world,' following cutting-edge military technology in general and the drone warfare revolution in particular.

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

In addition to Cantor Fitzgerald, HCA Healthcare also received a Buy from Truist Financial’s David S Macdonald in a report issued today. However, on the same day, Morgan Stanley maintained a ...

David Axe is a journalist and filmmaker based in Columbia, South Carolina. He joined Forbes in 2020, and currently focuses on Ukraine.

Cantor Fitzgerald analyst Jonathan Ruykhaver tells investors that the firm’s checks on Check Point (CHKP) remain consistent and “encouraging,” suggesting improved near-term performance.

"This will double our capacity immediately." ...

Amazon.com (AMZN) is one of the world's largest and most successful online retailers, offering a vast and diverse selection of products and services to consumers worldwide. Founded in 1994 by Jeff ...

In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...